1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE2. Research is primarily industry-sponsored.
21 publications have been identified in PubMed for systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease. Research spans Case Report / Case Series (29%), Review / Meta-Analysis (19%), and Clinical Trial Publication (19%).
Zhao Y (2026). [PMID: 40938150](https://pubmed.ncbi.nlm.nih.gov/40938150/). *Clinical nuclear medicine*. [Case Report / Case Series]
Gotlib J (2026). [PMID: 41604606](https://pubmed.ncbi.nlm.nih.gov/41604606/). *Blood advances*. [Clinical Trial Publication]
Reiter A (2026). [PMID: 41187902](https://pubmed.ncbi.nlm.nih.gov/41187902/). *The journal of allergy and clinical immunology. In practice*. [Other]
Ecker V (2025). [PMID: 40256960](https://pubmed.ncbi.nlm.nih.gov/40256960/). *Current protocols*. [Case Report / Case Series]
Aperna F (2025). [PMID: 40607735](https://pubmed.ncbi.nlm.nih.gov/40607735/). *American journal of hematology*. [Review / Meta-Analysis]
John MV (2025). [PMID: 40913208](https://pubmed.ncbi.nlm.nih.gov/40913208/). *Annals of hematology*. [Case Report / Case Series]
Dranitsaris G (2025). [PMID: 38151028](https://pubmed.ncbi.nlm.nih.gov/38151028/). *Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners*. [Diagnostic / Biomarker]
Ustun C (2025). [PMID: 40983528](https://pubmed.ncbi.nlm.nih.gov/40983528/). *British journal of haematology*. [Epidemiology / Natural History]
Radia DH (2025). [PMID: 39808818](https://pubmed.ncbi.nlm.nih.gov/39808818/). *Blood*. [Review / Meta-Analysis]
Soare D (2025). [PMID: 40893810](https://pubmed.ncbi.nlm.nih.gov/40893810/). *Journal of medicine and life*. [Epidemiology / Natural History]
